Scarica l'app Stockscreener
24.51
8.68%
-2.33
Dopo l'orario di chiusura:
24.58
0.07
+0.29%
Precedente Chiudi:
$26.84
Aprire:
$26.42
Volume 24 ore:
1.88M
Relative Volume:
0.70
Capitalizzazione di mercato:
$3.06B
Reddito:
-
Utile/perdita netta:
$-238.77M
Rapporto P/E:
-0.9143
EPS:
-26.808
Flusso di cassa netto:
$-216.62M
1 W Prestazione:
-0.04%
1M Prestazione:
+148.08%
6M Prestazione:
+497.80%
1 anno Prestazione:
+264.73%
Intervallo 1D:
$24.44
$26.63
Intervallo di 1 settimana:
$23.45
$28.29
Portata 52W:
$2.7601
$28.29
Alumis Inc Stock (ALMS) Company Profile
Nome
Alumis Inc
Settore
Industria
Telefono
650-231-6625
Indirizzo
280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO
Confronta ALMS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ALMS
Alumis Inc
|
24.51 | 3.35B | 0 | -238.77M | -216.62M | -26.81 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.90 | 120.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.45 | 78.77B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
840.50 | 52.46B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
338.06 | 45.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
340.38 | 38.73B | 4.98B | 69.59M | 525.67M | 0.5197 |
Alumis Inc Stock (ALMS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-21 | Iniziato | Chardan Capital Markets | Buy |
| 2025-07-25 | Iniziato | Wells Fargo | Overweight |
| 2025-06-10 | Ripresa | Guggenheim | Buy |
| 2025-01-30 | Iniziato | Oppenheimer | Outperform |
| 2024-10-31 | Iniziato | Robert W. Baird | Outperform |
| 2024-10-17 | Iniziato | H.C. Wainwright | Buy |
| 2024-07-23 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-07-23 | Iniziato | Guggenheim | Buy |
| 2024-07-23 | Iniziato | Leerink Partners | Outperform |
| 2024-07-23 | Iniziato | Morgan Stanley | Overweight |
Mostra tutto
Alumis Inc Borsa (ALMS) Ultime notizie
Chardan Highlights Alumis’s (ALMS) Potential After Envudeucitinib Hits All Phase 3 Endpoints in Psoriasis Trials - Insider Monkey
Top Small Cap Stocks To Watch NowJanuary 6th - MarketBeat
10 New Stocks on the Rise - Insider Monkey
Alumis stock hits all-time high at 27.28 USD By Investing.com - Investing.com Canada
Alumis stock hits all-time high at 27.28 USD - Investing.com
Alumis (NASDAQ:ALMS) Trading Up 6.4%Should You Buy? - MarketBeat
Stock Market Today, Jan. 6: Alumis Shares Surge on Positive Phase 3 Psoriasis Data for Envudeucitinib - AOL.com
Alumis Inc. (ALMS) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Alumis (NASDAQ:ALMS) Coverage Initiated by Analysts at Chardan Capital - MarketBeat
Alumis Inc. (ALMS) Stock Analysis: Exploring A 39% Upside In The Biotech Arena - DirectorsTalk Interviews
Alumis stock reaches all-time high at 25.25 USD By Investing.com - Investing.com Australia
This Crescent Biopharma Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga
Chardan Capital initiates coverage on Alumis stock with Buy rating - Investing.com
Chardan Capital initiates coverage on Alumis stock with Buy rating By Investing.com - Investing.com India
Alumis (NASDAQ:ALMS) Hits New 12-Month HighWhat's Next? - MarketBeat
Profit Recap: Is now the right time to enter ASTCJuly 2025 WrapUp & Technical Confirmation Alerts - baoquankhu1.vn
Trading Recap: Is Alumis Inc gaining market shareJuly 2025 Market Mood & Growth Focused Entry Point Reports - baoquankhu1.vn
Aug Reactions: What is the long term forecast for XPLR Infrastructure LP Limited Partnership stock - baoquankhu1.vn
Alumis stock reaches all-time high at 25.25 USD - Investing.com
Aug Weekly: What’s Enterprise Products Partners L.P. Limited Partnership’s historical returnMarket Activity Report & Daily Risk Controlled Trade Plans - baoquankhu1.vn
Huge Insider Buying Now at This Insurance Giant and 2 Biotechs - 24/7 Wall St.
Alumis (ALMS) Is Up 22.0% After Phase 3 Psoriasis Win And $300 Million Equity Raise - Yahoo Finance
HC Wainwright & Co. hikes Alumis Inc. (ALMS)’s price target to $40 from $20, reiterates buy rating - MSN
Alumis (ALMS) price target increased by 79.14% to 36.28 - MSN
An Almus (ALMS) Insider Bought 588,000 Shares for $10.0 Million - AOL.com
Staar Surgical, Alumis, and more stocks see action from activist investors - MSN
Staar Surgical, Alumis, and More Stocks See Action From Activist Investors - Barron's
Russell 2000 Kicks Off 2026 Strong, Surging Over 7% Year-to-Date - Intellectia AI
14 Best Booming Stocks to Buy Right Now - Insider Monkey
HC Wainwright & Co. Hikes Alumis Inc. (ALMS)’s Price Target To $40 From $20, Reiterates Buy Rating - Insider Monkey
Why is ALMS stock rising today? - MSN
Alumis (ALMS) Is Up 35.8% After Psoriasis Data And $300M Raise Has The Bull Case Changed? - simplywall.st
Alumis (ALMS) stock jumps as insider filings show $17 buys — what investors are watching next - TechStock²
Why Alumis Inc. Stock Is Surging Right Now - TipRanks
Alumis (NASDAQ:ALMS) Stock Price Up 6.6% Following Insider Buying Activity - MarketBeat
Alumis' Meteoric Rise To $20 From $5 In Just 60 Days On Plaque Psoriasis Trial Results - RTTNews
Akkaraju of Alumis buys shares worth $9.9 million By Investing.com - Investing.com Nigeria
Alumis (ALMS) Price Target Increased by 79.14% to 36.28 - Nasdaq
Alumis Inc stock hits all-time high at 22.33 USD By Investing.com - Investing.com Nigeria
Assessing Alumis (ALMS) Valuation After Positive Phase 3 Psoriasis Data And Follow On Equity Offering - simplywall.st
Insider Makes Bold Multimillion-Dollar Bet on Alumis Inc. - TipRanks
Insider Buying: Alumis (NASDAQ:ALMS) Director Purchases 588,235 Shares of Stock - MarketBeat
Aug Sectors: Will Alumis Inc stock benefit from automation2025 Performance Recap & Low Drawdown Momentum Trade Ideas - moha.gov.vn
Akkaraju of Alumis buys shares worth $9.9 million - Investing.com
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Hedge Fund and Insider Trading News: Bill Ackman, Ray Dalio, Warren Buffett, Balyasny Asset Management, Schonfeld Strategic Advisors, Renaissance Technologies, Anson Investments, Limoneira Co (LMNR), Alumis Inc (ALMS), and More - Insider Monkey
Alumis (NASDAQ:ALMS) Reaches New 1-Year High on Insider Buying Activity - MarketBeat
Alumis Inc Azioni (ALMS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.27%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):